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ABSTRACT
Diabetes mellitus (DM) in Indonesia has rapidly increased during recent years. 
World Health Organization (WHO) predicted that in 2030, Indonesia would 
be ranked fourth for the largest DM patients in the world. As the disease 
progresses, uncontrolled type 2 DM (T2DM) results in dry skin as the most 
prevalent skin disorder. Despite the prevalence and morbidities that lead to 
infection, ulcer, gangrene that can lead to amputation when insufficiently 
treated, dry skin in T2DM has limited therapeutic options. Currently, available 
therapies for dry skin in T2DM have not considered factors of hyperglycemia 
and hyperinsulinemia, which disturb skin homeostasis. Nonetheless, in T2DM, 
there are neuropathy and biostructural changes of the skin which induce 
dry skin. Alternative herbal medicine, Centella asiatica is getting well-known 
nowadays because of its vast amount of benefits. Centella asiatica has been 
studied for its antioxidant, antidiabetic, anti-inflammation, antiglycation, and 
neuroprotective activities. Furtherly, these properties may display benefits 
when introduced to T2DM dry skin therapy. The previous clinical study had 
shown that topical C. asiatica improved dry skin. This clinical study was also 
supported by in vitro studies. Currently, pharmacological profile studies of C. 
asiatica including dosage, toxicity, and safety have been available. This article 
aimed to review the current literature on the potential of C. asiatica as an 
alternative to treat dry skin in T2DM.
ABSTRAK
Diabetes mellitus (DM) di Indonesia terus meningkat pesat selama beberapa 
tahun terakhir. World Health Organization (WHO) memperkirakan pada tahun 
2030 Indonesia memiliki jumlah penderita terbanyak pada peringkat keempat 
di dunia. Pada perjalanan penyakit DM tipe 2 (DMT2) yang tidak terkontrol, 
kelainan kulit kering merupakan salah satu kelainan yang paling sering ditemui. 
Kulit kering pada DMT2 saat ini memiliki terapi terbatas padahal morbiditasnya 
tinggi, dapat menyebabkan infeksi, ulkus, dan gangren yang menyebabkan 
amputasi bila tidak tertangani dengan baik. Terapi yang ada saat ini belum 
melihat kelainan kulit kering pada DMT2 terjadi karena faktor hiperglikemia 
dan hiperinsulinemia yang mengganggu keseimbangan homeostasis kulit. 
Selain itu, pada DMT2, terjadi neuropati dan perubahan biostruktur kulit 
yang memicu kekeringan kulit. Terapi alternatif herbal, Centella asiatica saat 
ini sedang naik daun karena berbagai manfaatnya. Centella asiatica terbukti 
memiliki aktivitas antioksidan, antidiabetes, antiinflamasi, antiglikasi, dan 
neuroprotektif yang bermanfaat untuk pengobatan kulit kering pasien DMT2. 
Penelitian klinis sebelumnya menunjukkan bahwa pemberian C. asiatica 
topikal bermanfaat pada kulit kering yang didukung juga dengan penemuan 
penelitian in vitro. Saat ini sudah ada penelitian farmakologi C. asiatica yang 
meliputi dosis, toksisitas, dan keamanan. Tujuan dari artikel ini adalah untuk 
mengulas potensi dari C. asiatica sebagai terapi alternatif untuk kulit kering 
pada DMT2.
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INTRODUCTION
Diabetes mellitus (DM) in Indonesia 
has been growing progressively. 
According to WHO data, Indonesia is 
predicted to rank fourth in the world 
by 2030.1 Diabetes mellitus has cost 
Indonesia 810 million USD financially 
and became a national health burden. 
Patients with DM are projected to spend 
2.3 times health expenditure compared 
to healthy people as its complications 
increase morbidity and mortality.2
Skin is one of the organs affected by 
uncontrolled DM. A study by Chatterjee 
et al.3 found that 74% of type 2 DM 
(T2DM) patients suffered from a skin 
disorder, mainly dry skin (47%) which 
can become severe, leading to infection, 
ulcer, and gangrene. In an earlier stage, 
dry skin should be sufficiently treated to 
prevent these complications.3 However, 
options for treating dry skin of T2DM are 
still limited. Commonly used therapies 
for dry skin in T2DM have not accounted 
for the pathogenesis of T2DM-induced 
dry skin that involves hyperglycemia 
and hyperinsulinemia, leading to 
the disturbance of skin homeostasis. 
It is believed that neuropathy and 
biostructural changes of the skin 
occurred in T2DM, leading to dry skin.
Traditional herbal medicine has 
been emerging in the last few years. One 
of which is Centella asiatica, local name 
as pegagan in Indonesia or gotu kula 
and Indian pennyworth internationally. 
Centella asiatica, part of the Apiaceae 
family, has been long reputed to 
provide benefits as antipyretic, diuretic, 
antibacterial, antiviral, and cognitive 
enhancement agents. Centella asiatica 
has been studied to clinically improve 
dry skin in the geriatric population. 
Centella asiatica has also been linked to 
having antidiabetic properties.4,5 In this 
paper, we aimed to review the current 
literature on the potential of C. asiatica 
as an alternative to treat dry skin in 
T2DM.
DISCUSSION
Pathogenesis of dry skin disorder in 
T2DM
In T2DM, there are changes in the 
mechanical and functional properties 
of the skin. These changes will affect 
the homeostatic environment of the 
skin, commonly manifesting in dry 
skin. Unfortunately, dry skin tends to 
be underdiagnosed or ignored until 
it progresses into more severe skin 
disorders such as ulcers or gangrene.6
In DM animal models, an imbalance 
of stratum corneum components was 
observed. Triglyceride was found to 
be lower, while ceramide, cholesterol, 
and fatty acid were found to be higher 
compared to control. In addition, the 
study also found that the corneocytes 
in the stratum corneum increased in 
thickness and size. In contrast, the basal 
cell proliferation decreased, resulting in 
slower metabolism in epidermis.7,8
Skin disorder in DM patients 
resulted from cellular disturbances 
initiated by hyperinsulinemia and 
hyperglycemia. Hyperglycemic condition 
interrupts corneocyte proliferation.9 
Furthermore, the dermis also changes 
in morphology and biochemistry due to 
the degradation of matrix intracellular 
and microstructural components. In a 
study from Mozcar et al.10 biopsy of DM 
patients skin  revealed ultrastructural 
alteration of fibroblast, collagen, and 
elastic fiber of dermis. Fibroblasts had 
increased electron-dense deposits in 
the cytoplasm and dilated endoplasmic 
reticulum, collagens were dissociated, 
and elastic fibers were either fragmented 
or absent. Collagenase and elastase were 
also altered, resulting in macromolecular 
matrix changes.
Dry skin is affected extrinsically 
and intrinsically by numerous factors. 
Extrinsic factors include lifestyle 
(hot bath, alkali base soap, and air 
conditioning) and environment (UV 
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radiation, dry wind, cold temperature, 
and climate change). Intrinsic factors 
include advanced glycation end-
products (AGEs), urination, autonomic 
neuropathy, sebaceous gland production, 
barrier function of stratum corneum, 
and desquamation process.11
High blood glucose pathologically 
affects skin homeostasis through 
inhibition of proliferation and migration 
of keratinocytes, biosynthesis of protein, 
inducing apoptosis of endothelial cells, 
and lowering the synthesis of nitrite 
oxide. High blood glucose also impairs 
phagocytosis and is chemotactic of several 
cells. Based on in-vitro studies, high 
blood glucose disturbed proliferation 
and differentiation of keratinocytes—
nonetheless, hyperglycemia-induced 
AGEs formation. Several alterations in 
DM patients are summarized in TABLE 1.12
TABLE 1. Skin alteration in DM patients13 





Transepidermal water loss Insignificant changes Sakai, et al.14
Filaggrin Significant changes Thyssen, et al.16
Barrier integrity Increment Inflammation Infiltrate Tellechea, et al.17 




Despite the pathogenesis of dry skin 
in DM remains unclear, several factors 
are suspected to play a major role:
Systemic mechanism of dry skin in DM
Polyuria, as a common manifestation 
in DM patients, increases total body water 
loss, increasing the skin’s susceptibility 
to dryness.20
Neuropathy in DM patients
Neuropathy in DM patients can 
affect sensory, motoric, and autonomic 
pathways. Sensory neuropathy can 
cause sensibility and thermal sensation 
loss. Meanwhile, autonomic neuropathy 
can damage the neurological pathway 
controlling eccrine and sebaceous glands. 
The damaged neuron will decrease blood 
flow leading to atrophy of the glands. 
Atrophy of eccrine and sebaceous glands 
will decrease the production of lipid and 
sweat; thus, the skin tends to be dry. Dry 
skin is prominent in areas with eccrine 
gland only, such as the sole. The decrease 
in peripheral blood flow will increase 
the damage in dry skin in DM patients. 
Neuropathy can manifest independently 
or simultaneously and can be a 
precipitating factor to the leg ulcer.  Leg 
ulcers in DM patients are challenging to 
treat and pose a risk for severe infection, 
and amputation is a common approach 
in several cases.20,21
Biophysical changes in stratum corneum
In DM, there are biophysical changes 
in the stratum corneum caused by a 
change in lipid concentration, epidermal 
proliferation and differentiation, 
natural moisturizing factor (NMF), 
and aquaporin water channels (AQP3) 
that compromise the skin moisture 
network. Nonetheless, the study also 
showed thickening of the corneocyte 
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layer in stratum corneum, decrement 
of the proliferation of the basal cell, 
and damage to epidermal DNA which is 
essential for epidermal differentiation.
The mentioned factors decrease the 
metabolism rate of epidermis.7,14
In the study of animal models 
induced with DM, there was impairment 
in skin barrier, epidermal turnover rate, 
corneocytes accumulation, and decrease 
of lipid concentration. This founding 
was similar to a study in humans with 
DM where these conditions predispose 
to dry skin precipitate aging process in 
DM.14
Hydration status
Hydration status in rats with 
induced hyperglycemia was lower 
compared to normal rats, although 
there was an insignificant difference 
in transepidermal water loss (TEWL)
between the two groups.8,22 Sakai et al.14 
conducted a study comparing hydration 
status and TEWL in a group of patients 
with a high level of HbA1c and fasting 
blood glucose (FBG) and another group 
with low HbA1c and FBG. The study found 
that hydration status was significantly 
lower in the high FBG group, while 
TEWL was not different significantly. 
In addition, there was an insignificant 
increase in TEWL in patients with high 
HbA1c.14
Stratum corneum functional 
capacity in DM patient varied depending 
on current hyperglycemic state (FBG > 
110 mg/dL) and average blood glucose 
control (HbA1c > 5.8%). In the study by 
Sakai et al.,7 DM mice with FBG > 110 mg/
dL had lower skin hydration compared 
to FBG < 110 mg/dL, without difference 
in TEWL. In patients with HbA1c > 
5.8%, the TEWL value is slightly lower 
compared to HbA1c < 5.8% with no 
significant difference in skin hydration 
statistically. The study result showed 
that skin hydration is influenced by 
current hyperglycemia (FPG) rather 
than previous hyperglycemia (HbA1c).14 
Another study in DM patients with FBG > 
110 mg/dL and HbA1c > 5.8% showed that 
stratum corneum hydration and TEWL 
value were similar to control. However, 
in this study, there was a significant 
reduction of sebum and functional 
changes of the sebaceous gland that 
might contribute to the development of 
diabetic skin.15
Depletion of amino acid and lipid 
concentration
In the animal model with DM, change 
was not found in the concentration of 
amino acid (profilaggrin and filaggrin), 
but there was a decline of lipid in 
stratum corneum, mainly triglycerides, 
compared to normal.7,23  Seirafi et 
al.15 reported a lower concentration of 
lipid in the forehead of DM patients with 
high level of HbA1c and FBG compared 
to patients with low level of HbA1c and 
FBG. This finding is similar to the study 
in animal models. Decreased lipid in the 
skin is suspected to be caused by lipolysis 
in sebaceous gland in hyperglycemic 
condition.15
Decreased  proliferation and 
differentiation  of  epidermis
Diabetes mellitus influenced 
the structure, proliferation, and 
differentiation of the epidermis. In 
mice induced with DM the epidermis 
is thinner. In addition, the ratio of 
proliferating cell nuclear antigen (PCNA) 
basal cell per total basal cell in epidermis, 
and DNA concentration in epidermis is 
lower compared to non-DM. Corneocytes 
were found to be larger in mice with DM. 
This phenomenon was caused by the 
decrease in epidermal turnover rate.21,22
Insulin plays a role in keratinocytes 
proliferation and differentiation. In a rat 
model with induced DM and DM patients, 
there was a decrease in insulin signal 
transduction which causes a decline in 
keratinocyte migration, proliferation, 
and differentiation. These conditions 
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aggravated dry skin in DM patients by 
creating squama buildup.21,22
A study by Goyal et al.24 stated that 
dry skin was the earliest and the most 
prevalent skin abnormality found in 
DMT1 patients. The clinical observation 
indicated a decrement of hydration status 
of stratum corneum and sebaceous gland 
activity, without significant disturbances 
in stratum corneum barrier.
Centella asiatica 
Definition, phytochemistry, and active 
compounds 
Centella asiatica is a prostate 
stoloniferous plant from Apiaceae 
family, commonly known as gotu kola 
or Indian pennywort in America and 
Malaysia. In Indonesia, it is called 
pegagan. Therapeutic use of C. asiatica 
has been documented for thousands 
of years, mainly in Southeast Asia and 
Bangladesh, mainly used as antipyretic, 
diuretic, antibacterial, antiviral, and 
cognitive enhancement agents. In 
dermatology, C. asiatica is used as a 
therapy for wound, burn, hypertrophic 
scar, eczema, Morbus Hansen, psoriasis, 
and lupus erythematosus. Centella 
asiatica is also used in cosmetic and 
geriatric due to its antiaging capability 
through the mediation of collagen type I 
increase.25,26 
TABLE 2. Active compound in C. asiatica25
Group Active compound
Terpenoid Triterpen, asiaticoside, centelloside, madecassoside, brahminosid 
(saponin glikosida), asiatisentoat acid, centellic acid, centoic acid, 
madecassic acid , terminolic acid, and betulic acid
Terpenoid β-caryophyllene, trans β-farnesene and germacrene D (sesquiterpen), 
α-pinene and β-pinene
Fenol Flavonoid: kaempferol, kaempferol-3-o-β-d-glucuronide, castilliferol, 
quercetin, quercetin-3-o-β-d-glucuronide, castillicetin, apigenin, rutin, 
luteolin, naringin
Fenol Fenilpropanoid: rosmarinic acid, chlorogenic acid, 3.4-di-o-caffeoyl 
quinic acid, 1.5-di-o-caffeoyl quinic acid, 3.5-di-o-caffeoyl quinic acid, 
4.5-di-caffeoyl quinic acid, isochlorogenic acid
Fenol Tannin: tannin, phlobatannin
Extract of C. asiatica leaves consisted 
of chemical compounds with many 
benefits, including antimicrobial, 
antiinflammation, anticancer, 
neuroprotective, antioxidant, and wound 
healing. These benefits have been tested 
in studies and the bioactive compound has 
been identified.27 Centella asiatica is rich 
in active compounds, triterpene fraction; 
mainly asiaticoside, madecassoside, 
asiatic acid, and madecassic acid (TABLE 
2).25 Furthermore, TABLE 3 displays C. 
asiatica active compound biological 
properties.28
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TABEL 3. Biological properties of C. asiatica bioactive compound28 
Bioactive compound Biological properties
Asiatic acid Enhancing neuroglia formation, increasing wound healing with 
cuticle cornification, stimulating granulation and gene expression, 
increasing memory and learning capacity, antinociceptive 
activity, antiinflammation, acetylcholinesterase inhibition, and 
antiapoptosis 
Asiaticoside Antiinflammation, antioxidant, gene expression change 
stimulation, wound healing, neuroprotective activity, lessening 
scar formation, increasing collagen biosynthesis
Quercetin Anti-HIV-1, antiasthma, antibacterial, antihepatotoxin, 
antihypertension, antiinflammation, antitussive, antiviral, 
coroner vasodilator, antihypercholesterolemia, inhibitor 5-HT, 
smooth muscle relaxant, platelet aggregation inhibitor, 3.5-cAMP-
phosphodiesterase inhibitor, fatty acid synthesis inhibitor, 
aldose reductase, protein kinase C inhibitor; decrease capillary 
vulnerability, antioxidant
Quercitrin Antibacterial, antineoplastic, antihepatotoxic, antiinflammation, 
antimutagenic, antiviral, diuretic, hemostasis, aldose reductase 
inhibitor, antioxidant, insect antifeedant, insect phagostimulant, 
hepatoprotective
Kaempferol AntiHIV-1, antibacterial, antiinflammation, antitussive, 
antioxidant,  ∆5-lipoxygenase  inhibitor; deiodinase tironin 
iodinat  inhibitor, aldose reductase  inhibitor
Apigenin antibacterial, antiulcerative, antispasmodic, diuretic, inhibitor 
aldose reductase. antihypertensive, antiinflammation, 
antioxidant, nodulation signal for pea metabiosis, and Rhizobium 
leguminosarum
Luteolin antiallergy, antibacterial, antifungal, cytotoxic, anti inflammation, 
antispasmodic, antitussive, antiviral, improve arterial pressure 
and decrease venous pressure, increasing capillary permeability, 
enhancing immune system, increasing coronary flow, inhibitor 
of dihydrocoenzyme I (NADH) oxidase, iodine-induced thyronine 
deiodinase, and aldose reductase, antiinflammation, antiHIV
Naringin antibacterial, antiinflammation, antiviral, inhibitor aldose 
reductase, inhibitor anaphylactic cutaneous passive
Betulic acid antineoplastic, cytotoxic, antitubercular, antibacterial
α –Pinene antifungal, antitussive, irritant 
β-Pinene antifungal, antitussive, antiinflammation
Ascorbic acid antioxidant, antibacterial, antihypercholesterolemia, inhibition 
of carcinogen production, stimulating tissue to produce collagen, 
hematopoietic activity
Chlorogenic acid antioxidant, antineoplastic, cytotoxic, antimutagenic, antiviral, 
hemostatic, leukopoietic, antimalaria
Studies reported that asiaticoside, 
asiatic acid, and madecassic acid are 
capable of increasing collagen type 
I. Meanwhile only madecassoside 
is found to increase collagen type 
III. In fibroblast culture, fraction of 
triterpene in C. asiatica stimulates 
collagen synthesis and contributes in 
inflammation regulation, normalization 
of keratocyte hyperproliferation, and 
maintaining epidermal homeostatic.25
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Antioxidant activity
Centella asiatica is reported to have 
comparable antioxidant activity to 
rosemary extract, sage extract, vitamin 
C, and grape seed; Thus, C. asiatica has 
been studied as a natural antioxidant 
product. However, extraction methods 
also influence the antioxidant activity 
of the end-product. For example, when 
comparing water, ethanol, and light 
petroleum as extract solvent, ethanol 
has the highest antioxidant activity, 
followed by water, then petrolatum. 
Antioxidant activity in C. asiatica comes 
from hydroperoxide reduction which 
neutralizes free radicals and/or metallic 
ion bonds. There are several mechanisms 
of C. asiatica  antioxidant activity, some 
of which eliminate reactive oxygen 
species (ROS) (quercetin and catechin), 
inhibition of free radical formation, 
inhibition of chain breaker activity 
(p-coumaric acids), and metal binding.28
Leaves of C. asiatica contain the 
highest amount of antioxidant compared 
to other parts of the plant. Antioxidant 
activity of C. asiatica was mainly from 
hydroperoxide reduction, inactivation 
of free radicals, binding to metallic 
ions, and the combination of the three. 
Application of 0.2% asiaticoside cream 2 
times per day for 7 days in excision type 
wound scar increased enzymatic and 
non-enzymatic antioxidant, including 
superoxide dismutase (35%), catalase 
(67%), glutathione peroxidase (49%), 
vitamin E (77%) dan ascorbic acid 
(36%) in recently grown tissue. There 
was also a decrease in lipid peroxidase 
(69%). However, the application for 14 
days showed insignificant difference in 
antioxidant activity compared to control. 
The study concluded that asiaticoside 
induced antioxidant level in early phase 
of wound healing.28
Wound healing activity
In wound management, C. asiatica 
extract had been applied in chronic 
infection treatment. Aqueous extracts 
formulated in cream and gel were tested 
in rats to evaluate wound healing effect. 
It was found that C. asiatica  accelerated 
epithelization process and enhanced 
wound contraction.28 In animal models 
with scar injected with dexamethasone 
0.3 mg/kg, after CAo extract ethanol dose 
were increased from 1, 2, 4, 8, 16 mg/kg for 
14 days, the wound was healed.29 In the 
recent study in Thammasat University 
Hospital, DM patients consuming 100 
mg asiaticoside extract capsule three 
times per day showed improvement in 
wound contracture compared to placebo 
with no side effects.30 Asiaticoside effects 
in proliferation human periodontal 
ligament cell (HPDLs), protein synthesis, 
and osteogenic differentiation showed 
increase in periodontal tissue.31 In a 
study by Suwantong et al.32, asiaticoside 
in the form of crude asiaticoside 2% 
extract (CACE) and pure asiaticoside 
40% substances (PAC) were loaded into 
ultra-fine cellulose acetate fiber mats as 
topical/transdermal patches and wound 
dressing. Fiber mats loaded with PAC 
and CACE exhibited more significant 
proliferation of fibroblast and production 
of collagen. These loaded fiber mats were 
stable for up to 4 months.
Antiinflammatory activity
Asiatic acid and madecassic acid 
compounds in C. asiatica possessed anti-
inflammatory effect through inhibition 
of enzyme (iNOS, cyclooxygenase-2 
(COX-2)), interleukin (IL-6, IL-1β), and 
expression of cytokine tumor necrosis 
factor (TNF-α) with downregulation 
of NF-κβ activity in macrophage cell 
induced by lipopolysaccharide. In an 
animal study, asiaticoside inhibited fever 
and inflammation response triggered 
by lipopolysaccharide via obstructing 
the production of TNF-α, IL-6, liver 
myeloperoxidase activity, expression 
of COX-2 protein in the brain, and 
prostaglandin production.28
An in-silico study assessed binding 
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between C. asiatica active compounds 
and pro-inflammatory cytokines (IL-1α, 
IL-1β, and IL-6). The study also examined 
the interaction between C. asiatica active 
compounds and anti-inflammatory 
cytokines (IL-4). The study found that C. 
asiatica active compounds (asiaticoside, 
termolinic acid, madecassic acid, asiatic 
acid, batulinic acid, and madasiatic 
acid) interacted significantly with both 
proinflammatory cytokines (IL-1α, IL-
1β, and IL-6) and anti-inflammatory 
cytokines (IL-4).  Madecassic acid, 
asiaticoside, asiatic acid, madasiatic 
acid, and terminolic acid inhibit the 
pro-inflammatory cytokines by binding 
to receptor active sites of IL-1β and IL-
6. Madecassic acid, terminolic acid, and 
asiaticoside enhanced anti-inflammatory 
cytokines by binding to IL4 receptor 
binding sites.33
Antiaging activity
In fibroblast cell culture in human 
dermis, asiaticoside enhances the 
production of type-1 collagen. Based 
on this, C. asiatica was recommended 
in hypertrophic scar and keloid 
treatment. Centella asiatica ethanol 
extract exhibited antipruritic properties. 
Combination of ethanol extract with 
4 herbals (Curcuma caesia, Areca 
catechu, Cinnamon zeylanicum, dan 
Tamarindus indica) in cream formulation 
ameliorated skin hydration, sebum 
concentration, viscoelasticity, and lower 
melanin content.28 A study by Bylka 
et al. discussing C. asiatica benefit in 
cosmeticology showed that C. asiatica 
is effective in small wound treatment, 
hypertrophic scars, burn scars, psoriasis, 
and scleroderma. The mechanism 
of action was through fibroblast 
proliferation and collagen synthesis and 
intracellular fibronectin.
Anticancer activity
Each extract of C. asiatica solvent 
has an anticancer activity specific to 
different types of cells. Methanol extract 
of C. asiatica induces apoptosis in breast 
cancer cells in an in vitro study. Water 
extract of C. asiatica triggers apoptosis 
in tumorigenesis colon in male rat 
F344. Asiatic acid enhances apoptosis 
in human SK-MEL-2 melanoma which 
responds to skin cancer cells and colon 
cancer SW480 in humans. Asiaticoside 
increases antitumor vincristine in 
cancer cell. Methanol extract inhibits 
the proliferation of human gaster 
adenocarcinoma (MK-1), human uterus 
carcinoma (HeLa), and cells colarated to 
melanoma (B16F10).28
Antidiabetic activity
Ethanol and methanol extract of 
C. asiatica lower blood glucose level 
significantly to normal level in modeled 
animal rat diabetes-induced with 
alloxan.28
Neuroprotective activity
Centella asiatica is a potent 
antioxidant that exhibits a significant 
neuroprotective effect against oxidative 
damage due to aging in rat brains. 
Asiatic acid enhances oxidative cellular 
protection in the cerebral cortex. 
Therefore, C. asiatica showed efficacy 
in neuroprotection and preventing 
oxidative damage from excessive 
glutamate exposure. Centella asiatica 
accelerates neuron regeneration through 
oral medication containing several 
active fractions. These active fractions 
support neuron elongation in vitro hence 
improving neuron regeneration.4
Antiglycation activity
Active C. asiatica compounds showed 
a beneficial effect if applied topically on 
the skin for wound healing and chronic 
vein insufficiency. Maramaldi et al.25 
researched about purified C. asiatica 
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extract for skin wrinkling and skin 
protection against UV on human skin 
explant and human volunteer in a single-
blind placebo-controlled study. Antiaging 
properties observed were skin elasticity, 
plasticity, and collagen density. Thymine 
dimerization for DNA protection from 
UV was observed by immunostaining. 
Formation of malondialdehyde acts as 
an indicator for free radical scavenging 
activity, and expression of interleukin 1α 
as a proinflammation indicator observed 
with enzyme-linked immunosorbent 
assay (ELISA). This study also measured 
C. asiatica ability in vitro in inhibiting 
carboxymethyl lysine (CML), one of 
AGEs components, as an indicator for 
antiglycation activity.
In the study, Maramaldi et al.25 found 
that purified CA extract protected DNA 
from damages caused by UV lights by 
decreasing photo dimerized thymine 
up to 28% (p < 0.05). Expression of 
interleukin 1α also lowers up to 26% 
(p < 0.01), supporting C. asiatica as an 
antiinflammatory agent. In this study, 
C. asiatica purified extract completely 
prevented physiological glycation and 
was capable of compensating action 
of the glycating agent. Result of the 
in vitro study was confirmed by the 
clinical result, where intervention 
with C. asiatica 0.5% cream in healthy 
individuals improved wrinkle depth and 
volume, skin elasticity, and skin texture 
significantly (p < 0.05).
The molecular dynamic (MD) 
simulation study explored the molecular 
docking of C. asiatica active compound as 
an inhibitor of AGEs and receptor AGEs 
(RAGEs). Based on MD simulation in this 
study, C. asiatica active compounds have 
been proven to interact with both AGEs 
and RAGE. AGEs bound to asiaticoside, 
madasiatic acid, and madecassic 
acid with significant binding energy. 
Nonetheless, Asn106, Asp324, Asp376, 
Tyr420, and Tyr500 of AGEs made a 
significant contribution to the complex of 
asiaticoside-AGE. In the madasiatic acid-
AGEs, significant contribution was made 
by Asn118 and Tyr500. Meanwhile, it was 
found that RAGE bound to asiaticoside, 
asiatic acid, and isothankunik acid with 
significant binding energy.35
Study of C. asiatica’s benefits 
Moertolo et al.36 studied C. asiatica 
extract topical in atrophic scar post-
acne vulgaris. This in-vitro study 
used fibroblast cell culture which 
was given CA extract concentration 
0.6%, 0.8%, and 1.0%. Results showed 
C. asiatica significantly elevated 
fibroblast proliferation, depressed 
TNF-α, and metalloproteinase-1 (MMP-
1) concentration, and also promoted 
collagen I and III. Furthermore, the study 
was followed by an in vivo experiment 
with C. asiatica 0.8% mask in 94 subjects. 
The in vivo experiment found that C. 
asiatica 0.8%. The mask promoted faster 
healing and prevented atrophic acne 
scar formation compared to control.
Centella asiatica was also studied 
for its antioxidant properties. In a 2015 
study by Mohamed and Abdou,37 mice 
with streptozotocin-induced DM treated 
with C. asiatica 250 mg/kg/day for 14 
days showed an elated antioxidant 
capacity of the pancreatic cell and 
decreased MDA significantly compared 
to control. Another report found by 
Abdou and Mohamed,38 consumption 
of C. asiatica with the dosage of 250mg/
kg/day for 28 days improved superoxide 
dismutase (SOD), catalase (CAT), 
redacted glutathione (GSH), glutathione 
peroxidase (GPX), and lowered lipid 
peroxidase significantly in mice with 
streptozotocin-induced DM.
Topical use of C. asiatica extract is 
often associated with low bioavailability, 
poor fat solubility, and large molecule 
size, decreasing its absorption to skin 
and slowing skin distribution. Its efficacy 
in vivo is thus questioned. However, 
several studies had found that topical 
C. asiatica application still benefits the 
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skin despite its low bioavailability.39 
Maramaldi et al.25 found that topical 1% 
C. asiatica application in human skin 
explant showed antiinflammation and 
antiglycation properties by decreasing 
IL-1α and decreasing CML formation. 
This study was followed by a clinical 
experiment in healthy individuals 
which displayed that topical 0.5% C. 
asiatica improved wrinkles. Usage for 
6 weeks improved wrinkle depth and 
volume, skin elasticity, and skin firmness 
significantly (p<0.05).
Several studies look into the oral usage 
of C. asiatica extract. Anakunwithaya 
et al.40 studied the bioavailability of 
standard extract C. asiatica (ECa 233) in 
rats, measuring the main constituents 
which were madecassoside (53.1%) 
and asiaticoside (32.3%). ECa 233 were 
absorbed rapidly, although not entirely, 
in the gastrointestinal tract 5-10 min after 
administration. Both madecassoside and 
asiaticoside were distributed extensively 
in the brain, stomach, and skin within 1 
h and remained for at least 4 h. The oral 
bioavailability of madecassoside and 
asiaticoside were low. Madecassoside 
bioavailability was measured 0.19% 
for dose 50 mg/kg, 0.27% for 100 mg/kg, 
and 0,14% for 200 mg/kg. Meanwhile, 
asiaticoside bioavailability was measured 
0.15% for dose 50 mg/kg, 0.26% for 100 
mg/kg, and 0.16% for 200 mg/kg. Another 
study by Yuan et al.39 found that the 
bioavailability of C. asiatica compound 
asiatic acid with a dose of 20 mg/kg was 
16.25% in modeled rats.
Centella asiatica study in dry skin
Past studies had found that topical 
C. asiatica was able to repair skin 
hydration by increasing aquaporin-3 
(AQP-3) expression. Aquaporin-3 is a 
water channel that facilitates water 
movement from the dermis to epidermis. 
Nonetheless, topical C. asiatica has 
humectant ability which attracts 
moisture in the nearby environment 
and deeper skin layer to repair dry skin 
conditions.41 Wijayadi et al,41 reported 
that C. asiatica extract ethanol in chitosan 
nanoparticle with a concentration of 
3.125 mg/mL to 100 mg/mL was able to 
increase proliferation of fibroblast and 
keratinocyte, synthesis of collagen I 
and III, and expression of aquaporin-3 
(AQP-3) in fibroblast and keratinocyte. 
This study was followed by a clinical 
experiment by Hasanah et al,5 which 
studied C. asiatia extract ethanol in 
chitosan nanoparticle 1% and C. asiatica 
ethanol extract 1% in cream preparation 
in elderly dry skin. After six weeks of 
follow-up, the study found that both C. 
asiatica ethanol in chitosan nanoparticle 
extract 1% and C. asiatica ethanol extract 
1% improved dry skin, measured by 
specified symptom sum score (SRRC) and 
skin capacitance (SCap).
A comparative, three-arm RCT 
study analyzed the usage between of 
a combination of C. asiatica 2x1.100 
mg oral and C. asiatica 1% topical (CAo 
+ CAt) and C. asiatica 1% topical (Plo + 
CAt), and placebo (Plo +Plt) for treatment 
of dry skin in T2DM patients. The dry 
skin assessment (the measurement of 
SRRC and SCap) was performed on day 
1, 15, and 29, while evaluation of CML, 
IL-1α, and SOD activity was on day 1 
and 29. The study found that after 29 
days of treatment, the percentage of 
SRRC decrement in well-controlled blood 
glucose patients was greater in the CAo 
+ CAt group than the control group (p = 
0.04). The SCap value on day 29, the CAo 
+ CAt group also was greater than the 
control group (p = 0.01). In the partially 
controlled blood glucose, the increment 
of SOD activity in the CAo + CAt group 
was greater than the control group (p 
= 0.01). There was a medium-to-strong 
correlation between CML with SOD (r = 
0.58, p < 0.05) and IL-1α with SOD (r = 
0.70, p < 0.05) in well-controlled blood 
glucose. In the study, systemic and topical 
adverse events were not significantly 
different between groups.42
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Dosage of C. asiatica
The recommended dosage for C. 
asiatica are mentioned below:43 1). 
Oral C. asiatica extract 60 mg 2-3 times/
day, 2). Centella asiatica 1% cream 
daily. In C. asiatica studies, patients 
with chronic vein insufficiency were 
generally advised to consume C. 
asiatica supplement 2-3 times daily. 
Total saponin (asiatic acid, madecassic 
acid, asiaticoside, and madecassoside) 
were 30-60 mg per consumption with 
the total ranging from 60-180 mg daily. 
Centella asiatica also showed a potential 
benefit in enhancing cognitive function. 
Rats given 200-300 mg/kg C. asiatica 
dosage showed a significant increase in 
cognitive function. This study predicted 
that similar dosages would enhance 
cognitive function in humans; however, 
human study has not been conducted 
yet. Based on the calculation, 2100-3300 
mg could be used in 68 kg, 2900-4400 
could be used in 91 kg, 3600-5500 mg 
could be used in 113 kg. In another study, 
500 mg of C. asiatica consumed two times 
daily was effective in treating anxiety in 
human. This study also concluded that 
750 mg of 5% asiaticoside 5% was able to 
increase mood state.44
A study observed asiaticoside 
plasma concentration in humans after 
consuming a total triterpenoid fraction 
30-60 mg twice a day. The study found that 
a dosage of 30 mg increased asiaticoside 
plasma to 700 ± 110 ng/mL after single 
dose, and after 6 days the concentration 
in plasma was found to be 1.03 ± 0.05 μg/
mL (Tmax 4.1–4.5 h). Meanwhile, a 60 mg 
dosage increased plasma concentration 
to 1.36 ± 0.13 µg/mL and after 6 days the 
concentration peaked at 1.69 ± 0.07µg/
mL (Tmax 4.2 h). Half time in humans 
varied in different dosage and duration, 
the half time when using single dose 
with 30 mg was 2.20 ± 0.30 h and 60 mg 
was 3.40 ± 0.68 h, then when consumed 
for 6 days 30 mg was 6.33 ± 1.82 h and 60 
mg was 10.28 ± 1.8 h.45
In Abdou and Mohammed38 
reported that 250 mg/kg/day C. asiatica 
in modeled rat ameliorated activity 
of SOD, CAT, GSH, and GPX, as well as 
lowered lipid peroxidase significantly 
in streptozotocin-induced DM model rat 
in 28 days. In another study, C. asiatica 
with dosage of 250 mg/kg/day enhanced 
antioxidant capacity in pancreatic cell 
and decreased MDA concentration 
compared to control in streptozotocin-
induced DM model rat after 14 days.37
Both dosages used in the study were 
250 mg/kg/day in streptozotocin-induced 
DM modelled rat. This dosage in the rat 
model was then converted to human 
dose. Study by Reagan-Shaw et al.46 
calculated conversion to human dosage 
based on body surface area (BSA), 
estimated by 40.54 mg/kg.
In a study conducted by Legiawati 
et al,42 T2DM patients with dry skin 
were treated with a combination of C. 
asiatica 2x1.100 mg oral and C. asiatica 
1% topical (CAo + CAt), C. asiatica  1% 
topical (Plo + CAt), and placebo (Plo + 
Plt). In the group treated with CAo + 
CAt with well-controlled blood glucose, 
there was a significant percentage of 
SRRC decrement and significant SCap 
improvement after 29 days of therapy. 
The study also found significant SOD 
activity increments in the partially 
controlled blood glucose group after 29 
days of treatment with CAo + CAt.
Toxicity and safety
Test for acute toxicity in standardized 
C. asiatica extract (ECa 233) showed 
that a single dose of 10 g/kg was the 
highest dosage tolerable by rat models 
without acute toxicity effect, death, and 
pathological lesion. Therefore, LD50 value 
to 10 g/kg indicated safety limitation 
for ECa 233 where the effective dose 
for memory enhancement was 10 to 30 
mg/kg. In a test for subchronic toxicity, 
Wistar rats treated with ECa 233 with 
doses 10, 100, and 100 mg/kg/day for 
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90 days were not experiencing weight 
changes, food consumption, and health 
of model animals. There was a significant 
leucocyte count in the group treated with 
the highest dose, however it was not 
considered as leukocytosis. ECa 233 also 
did not induce any significant changes 
in blood chemistry or microscopic organ 
alteration.47
Side effects commonly found in 
C. asiatica oral usage are intestinal 
problems, nausea, photosensitivity, 
pruritus, hypercholesterolemia, 
hypertension, hypertriglyceridemia, and 
sedation. In topical form, side effects of C. 
asiatica are allergic contact dermatitis. In 
spite of that, the frequency report of side 
effects was unavailable. There was no 
significant contraindication reported.43
To this days, there was not any 
record of C. asiatica interaction with 
other drugs. Precaution must be taken 
while consuming C. asiatica with these 
drugs:
Sedative drug (central nervous system 
depressant)
Centella asiatica consumption 
could cause drowsiness. Combination 
of C. asiatica  with these drugs will 
increase drowsiness. These drugs 
include clonazepam,  lorazepam, 
phenobarbital.43
Hepatotoxic drug
Several drug induced hepatotoxicity 
including: acetaminophen, amiodarone, 
carbamazepine, isoniazid, methotrexate, 
methyldopa, fluconazole, itraconazole, 
erythromycin, phenytoin, simvastatin.43
Antidiabetic drug
Centella   asiatica    displays 
antidiabetic effect; thus, combination 
with other antidiabetic drugs is 
precautioned for hypoglycemia. 
Examples of commonly used 
antidiabetics are acarbose, glimepiride, 
glikuidon, insulin, and metformin.43
Jorge et al.48 reported three cases 
of women age 61, 52, and 49 years 
old experiencing jaundice after 
consumption of C. asiatica for 30, 20, 
and 60 days. In this report dosage and 
formulation of C. asiatica were not 
mentioned. In the three patients, there 
was an increase of serum glutamic 
oxaloacetic transaminase (SGOT), serum 
glutamic pyruvic transaminase (SGPT), 
and bilirubin. After C. asiatica was 
discontinued and ursodeoxycholic acid 
therapy was initiated at 10 mg/kg day, 
the three patients recovered.
Rahman et al.49 studied the 
antioxidant effect of C. asiatica by 
measuring antioxidant capability of 
active compounds in C. asiatica. The 
active compounds were polyphenol, 
flavonoid total, β-karoten, tannin, and 
vitamin C. The study was conducted with 
three solvents, which are ethanol 100%, 
ethanol 50%, and water. The conclusion 
was that the reduction power of total 
50% ethanol extract C. asiatica (63.4 ± 
1.7 μg AE/mL) was significantly higher 
than 100% extract ethanol CA (40.4 ± 0.7 
μg AE/mL) and extract water C. asiatica 
(56.3 ± 0.6 μg AE/mL). The biological 
potential of CA extract was high and 
very hygroscopic thus the extract could 
survive in room temperature.50
Three-arm study in T2DM patients 
with dry skin treatment was using C. 
asiatica 2x1.100 mg oral and C. asiatica 
1% topical (CAo + CAt), C. asiatica 1% 
topical (Plo + CAt), and placebo (Plo 
+Plt). In the study, both oral and topical 
adverse events were addressed, with 
each subject experiencing more than 
one adverse event. The oral adverse 
events assessed in the study include 
gastrointestinal symptoms, sedation, 
increase in urination, abdominal 
pain, back pain, erectile dysfunction, 
hoarseness in voice, vertigo, palpitation, 
recurring urticaria, herpes zoster, 
Bell’s palsy, and vaginal bleeding. The 
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oral adverse events were found to be 
indifferent between three groups. The 
topical adverse events complained 
by subjects were burning sensation, 
tenderness, and mild pruritus. However, 
the differences were insignificant among 
treatment groups. SGOT and SGPT were 
also measured on day 1 and 29 in all 
treatment groups. It was found that 
SGOT and SGPT value were not increased 
or differed significantly among the three 
groups.42
CONCLUSION
Based on this review, dry skin in 
T2DM involves the pathological process 
of hyperglycemia and hyperinsulinemia. 
There are also several biostructural 
changes of the skin related to T2DM which 
induces dry skin condition. Centella 
asiatica, with its antioxidant, wound 
healing, antiinflammation, antiaging, 
anticancer, antidiabetic, neuroprotective 
properties is expected to improve dry 
skin condition of T2DM. Results of 
several studies conducted to observe C. 
asiatica’s benefits have been positive. 
Namely, clinical studies of C. asiatica 
have improved dry skin conditions in 
geriatric and T2DM patients. In addition, 
the toxicity, safety, and dosage.
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